Ethanol Extract of Liriodendron Chinense (hemsl.) Sarg Barks Attenuates Hyperuricemic Nephropathy by Inhibiting Renal Fibrosis and Inflammation in Mice.
Jing Pan,Chunle Zhang,Min Shi,Fan Guo,Jing Liu,Lingzhi Li,Qian Ren,Sibei Tao,Minghai Tang,Haoyu Ye,Liang Ma,Ping Fu
DOI: https://doi.org/10.1016/j.jep.2020.113278
IF: 5.195
2020-01-01
Journal of Ethnopharmacology
Abstract:Ethnopharmacological relevance: Liriodendron chinense (Hemsl.) Sarg, known as the Chinese tulip tree, has a long history of cultivation and utilization in many Asia countries, especially in China to use in traditional Chinese medicine for expelling "wind and dampness", a term corresponding to rheumatic fever and rheumatoid arthritis. Interestingly, the barks of Liriodendron chinense (Hemsl.) Sarg was also found in folk to treat gout. However, further experimental studies remained to confirm its uric acid-lowering effects. Aim of the study: The aim of the study was to evaluate the protective effect of ethanol extract of the barks of Liriodendron chinense (Hemsl.) Sarg (EELC) in a mouse model of hyperuricemic nephropathy (HN) and the involved mechanisms. Materials and methods: EELC at a respective dose of 250 mg/kg/d or 500 mg/kg/d were orally administered to HN mice induced by a mixture of adenine (160 mg/kg/d/potassium oxonate (2.4 g/kg/d) for 21 days. At the end of the treatment, serum uric acid, kidney functions (serum creatinine, blood urea nitrogen and urine microalbumin), 24-h urine uric acid excretion, as well as kidney pathological changes were investigated by biochemical assay, histopathological score, immunofluorescence and histochemistry, RT-qPCR, and western blotting analysis. Results and Discussion: Oral administration of EELC significantly lowered serum uric acid level at 500 mg/kg (185.75 +/- 15.49 mu mol/L of EELC vs. 238.28 +/- 20.97 mu mol/L of HN model, p < 0.01) in HN mice. EELC at 500 mg/kg also remarkably reduced the levels of serum creatinine (82.92 +/- 7.86 mu mol/L of EELC vs. 92.08 +/- 6.13 mu mol/L of HN model, p < 0.0001), blood urea nitrogen (21.50 +/- 1.87 mmol/L of EELC vs. 29.40 +/- 3.95 mmol/L of HN model, p < 0.001) and urine microalbumin (4.25 +/- 0.40 mg/L of EELC vs. 5.95 +/- 0.33 mg/L of HN model, p < 0.001) to improve renal function. It also attenuated renal fibrosis, especially the high-dose of EELC. Furthermore, EELC could inhibit the activation of NF-kappa B, ASK1/JNK/c-Jun, JAK2/STAT3 signaling pathways and reduce the release of pro-inflammatory cytokine TNF-alpha in the kidneys of HN mice. Additionally, EELC remarkably increased urine uric acid excretion of HN mice, which may be achieved by the upregulation of organic anion transporter 1 (OAT1), OAT3 and ATP-binding cassette subfamily G member 2 (ABCG2) proteins. Conclusions: EELC alleviated the progression of HN by suppressing the activation of NF-kappa B, ASK1/JNK/c-Jun and JAK2/STAT3 signaling pathway, reducing the infiltration of inflammatory factors and uric acid accumulation in the kidney.